LifeVantage (NASDAQ:LFVN) Shares Cross Below 200-Day Moving Average - Should You Sell?

LifeVantage Co. (NASDAQ:LFVN - Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $16.28 and traded as low as $12.79. LifeVantage shares last traded at $13.37, with a volume of 173,215 shares.

LifeVantage Price Performance

The firm has a market capitalization of $162.13 million, a price-to-earnings ratio of 23.00 and a beta of 0.41. The business's 50-day moving average price is $13.30 and its 200 day moving average price is $16.25.

LifeVantage (NASDAQ:LFVN - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.10. The company had revenue of $58.44 million during the quarter, compared to analysts' expectations of $60.99 million. LifeVantage had a net margin of 3.46% and a return on equity of 34.29%.

LifeVantage Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 30th will be paid a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a yield of 1.40%. This is a boost from LifeVantage's previous quarterly dividend of $0.04. The ex-dividend date of this dividend is Friday, May 30th. LifeVantage's dividend payout ratio (DPR) is presently 26.09%.

Institutional Investors Weigh In On LifeVantage

A number of hedge funds have recently made changes to their positions in LFVN. Bank of New York Mellon Corp raised its position in LifeVantage by 43.9% in the fourth quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company's stock worth $1,300,000 after acquiring an additional 22,620 shares in the last quarter. O Shaughnessy Asset Management LLC increased its holdings in shares of LifeVantage by 56.2% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 93,576 shares of the company's stock valued at $1,640,000 after purchasing an additional 33,658 shares during the period. Susquehanna International Group LLP boosted its holdings in shares of LifeVantage by 83.5% during the fourth quarter. Susquehanna International Group LLP now owns 128,082 shares of the company's stock worth $2,245,000 after purchasing an additional 58,279 shares during the period. Barclays PLC grew its position in LifeVantage by 3.6% during the fourth quarter. Barclays PLC now owns 43,472 shares of the company's stock valued at $763,000 after purchasing an additional 1,506 shares in the last quarter. Finally, LPL Financial LLC increased its stake in LifeVantage by 301.0% in the 4th quarter. LPL Financial LLC now owns 211,039 shares of the company's stock valued at $3,700,000 after buying an additional 158,405 shares during the period. Institutional investors own 35.32% of the company's stock.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.